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Abstract
Background: The identification of factors that compromise neurogenesis is aimed at improving stem cell-based
approaches in the field of regenerative medicine. Interferon gamma (IFNg) is a main pro-inflammatory cytokine and
up-regulated during several neurological diseases. IFNg is generally thought to beneficially enhance neurogenesis
from fetal or adult neural stem/precursor cells (NSPCs).
Results: We now provide direct evidence to the contrary that IFNg induces a dysfunctional stage in a substantial
portion of NSPC-derived progeny in vitro characterized by simultaneous expression of glial fibrillary acid protein
(GFAP) and neuronal markers, an abnormal gene expression and a functional phenotype neither typical for neurons
nor for mature astrocytes. Dysfunctional development of NSPCs under the influence of IFNg was finally
demonstrated by applying the microelectrode array technology. IFNg exposure of NSPCs during an initial 7-day
proliferation period prevented the subsequent adequate differentiation and formation of functional neuronal
networks.
Conclusions: Our results show that immunocytochemical analyses of NSPC-derived progeny are not necessarily
indicating the correct cellular phenotype specifically under inflammatory conditions and that simultaneous
expression of neuronal and glial markers rather point to cellular dysregulation. We hypothesize that inhibiting the
impact of IFNg on NSPCs during neurological diseases might contribute to effective neurogenesis and
regeneration.
Background
Neural stem/precursor cells (NSPCs) may be useful as
an endogenous or transplantable source of newly gener-
ated neural cells, which can replace lost or diseased
neurons within the central nervous system (CNS) [1].
A prerequisite for this is an appropriate functional dif-
ferentiation of immature neural cells into electrophysio-
logically active neurons. As nearly all CNS diseases
involve acute and chronic inflammatory processes [2], it
is crucial to understand NSPC development under
inflammatory conditions to better realize their full
potential. IFNg is a key inflammatory cytokine, mainly
produced by cytotoxic CD8
+ T-cells and natural killer
cells in the course of neurological diseases like cerebral
traumata [3], stroke [4] or multiple sclerosis [5]. Beside
the observation that IFNg-activated microglial cells
induce neurogenesis [6], IFNg has also been reported to
exert beneficial, pro-neurogenic effects on NSPC devel-
opment in vitro and in vivo in a number of recent pub-
lications independently of microglial cells [7-9].
However, a hint that IFNg might be involved in poten-
tially harmful developmental dysregulation was detected
in a number of reports [10-12] and from its tumor-
initiating role, since embryonic mice over-expressing
IFNg develop medulloblastomas [13], indicating that
IFNg may also be involved in malignant transformation
of neural precursor cells.
In the present study, we demonstrated that IFNg
induces an abnormal immunocytochemical phenotype in
NSPCs with simultaneous expression of neuronal and
glial markers. Furthermore, IFNg led to a dysregulated
gene expression as well as dysfunctional electrophysiolo-
gical properties. Additionally, we finally present evidence
that IFNg exposure to NSPCs during an initial 7-day
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development of functional neuronal networks as
recorded by the microelectrode array technology. Our
data clearly indicate that IFNg compromises neurogen-
esis. Thus, its role during inflammatory processes should
be reassessed and IFNg suppression during brain pathol-
ogy possibly supports functional neurogenesis.
Results
IFNg receptors 1 and 2 are expressed in NSPCs and their
differentiated progeny
Experiments were performed either with proliferating
NSPCs under the influence of growth factors which
expressed immature neural markers like Sox2 and nestin
(Figure 1A) or with the differentiated progeny of NSPCs
that lost their immature markers and instead expressed
bIII-tubulin or GFAP (Figure 1B). The signal transduc-
tion process of the proinflammatory cytokine IFNg starts
with binding to the IFNg receptor (IFNGR). This
receptor comprises two ligand-binding IFNG-R1 chains
which are associated to two signal-transducing IFNG-R2
chains. Both domains of the receptor belong to the class
II cytokine receptor family. To study effects of IFNg on
NSPCs and their differentiated progeny, we confirmed
the expression of IFNG-R1 and IFNG-R2 in proliferating
or differentiated NSPC cultures (Figure 1). We per-
formed immunocytochemical experiments to demon-
strate the expression on protein level (Figure 1B). Then
we compared the mRNA expression levels of both
receptor domains by means of real-time quantitative
PCR in various mouse tissues in comparison to prolif-
erative or differentiated NSPCs (Figure 1C). Our results
indeed confirmed the presence of both receptor
domains in proliferative as well as differentiated NSPCs.
IFNg reduces the population extent of NSPCs
To investigate effects of IFNg on the extent of NSPC
populations we performed an MTT-assay. We could
Figure 1 NSPCs express receptors for IFNg. In a: Photomicrographs of proliferating NSPCs (NSPC-p) immunocytochemically labeled against
Sox2 and nestin. In b: Photomicrographs of proliferating (NSPC-p) or differentiated (NSPC-d) NSPCs with indicated immunocytochemical markers
are given showing that both receptors are expressed on individual cells. In c: real-time quantitative PCR with primers specific for IFNg-R1 or IFNg-
R2 illustrate the expression of both IFNg receptors on proliferating (NSPC-p) or differentiated (NSPC-d) NSPCs. Controls are spleen or total brain
homogenates. Values are means +/- standard error of mean (SEM). Experiments were performed in triplicate and repeated independently at least
three times.
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Page 2 of 12demonstrate that 100 or 1000 Units of IFNg/ml led to
significant reductions in the population extent during 48
hours under proliferative conditions (Figure 2A). To
verify whether cytotoxic or apoptotic mechanism were
involved, we verified caspase 3/7 activity during IFNg
exposure and found a significant increase when caspase
activity was measured by means of the Caspase-Glo 3/7
assay (Figure 2B). Also an increased immunocytochem-
ical labeling against caspase 3/7 protein (Figure 2C) sug-
gested an induction of apoptotic pathways in NSPCs
after IFNg treatment. To detect possible anti-prolifera-
tive influences of IFNg on NSPC populations, we per-
formed BrdU labelings. Here, we were able to detect an
additional slight but significant anti-proliferative effect
of IFNg (Figure 2D). Together, these data show that
IFNg exerts apoptotic and anti-proliferative effects on
NSPCs that together lead to reduced population extents
even under the influence of FGF-2.
IFNg induces an abnormal phenotype in NSPCs
In the present study, we found that IFNg treatment of
proliferative murine E14 neurosphere-derived NSPCs
caused up-regulation not only of transcripts for bIII-
tubulin or microtubule-associated protein 2a-c (MAP2a-
c), established markers for post-mitotic neurons, but
also for the astrocyte marker glial fibrillary acidic pro-
tein (GFAP), challenging the prevalent view of a predo-
minatly pro-neurogenic effect of IFNg.A tt h es a m e
time, IFNg executed a down-regulation of CD133, a
marker for immature NSPCs, which indicated a robust
activation of differentiation programs despite the pre-
sence of growth factors (Figure 3A). Immunocytochem-
ical experiments confirmed these results: on the one
hand, we could detect an anti-proliferative effect of
IFNg as numbers of BrdU
+ cells decreased (Figure 2D).
On the other hand, we detected a robust increase in the
number of cells expressing neuronal and glial specific
proteins after IFNg treatment (Figure 3B). Surprisingly,
in addition to GFAP
-/bIII-tubulin
+ or GFAP
+/bIII-tubu-
lin
- cells, a considerable number of NSPCs (39.3 ±
14.5% of all cells) co-expressed GFAP and bIII-tubulin
after a 3-day treatment with 1000 U/ml IFNg (Figure
3B). GFAP
+/bIII-tubulin
+ cells in comparable numbers
were also detectable after IFNg treatment with only 100
U/ml (Figure 3B). Using a concentration of 100 U/ml
IFNg led to a slightly weaker induction of GFAP and
bIII-tubulin immunoreactivity in individual cells while
numbers of cells showing at all this phenomenon were
similar with 100 or 1000 U/ml. This phenomenon was
absolutely rare (< 0.01%) in the absence of IFNg (Figure
3B). In addition, IFNg treatment induced simultaneous
expression of GFAP and the post-mitotic neuronal mar-
k e r sM A P 2 a - ci nal a r g ep e r c e n t a g eo fc e l l s( G F A P
+/MAP2a-c
+: 73.6 ± 5.7%), illustrating that the co-
expression of glial and neuronal markers is not
restricted to bIII-tubulin. We next investigated the influ-
ence of IFNg treatment during a 7-day differentiation
period after growth factor withdrawal from NSPC cul-
tures to elucidate effects on cell maturation. Again, we
detected cells co-expressing GFAP and bIII-tubulin (Fig-
ure 4A). Moreover, numbers of GFAP
-/bIII-tubulin
+ or
GFAP
+/bIII-tubulin
- cells in IFNg treated cultures differ-
entiated for 7 days were significantly lower than without
IFNg Figure 4A), which is in direct contrast to the
expected pro-neurogenic role of IFNg. As terminal neu-
ronal differentiation could take longer than 7 days, we
also cultured NSPC populations without growth factors
for 14 or 21 days under the influence of IFNg. Also here
we found GFAP
+/bIII-tubulin
+ cells indicating that this
phenotype is stable during 14 or 21 days under differen-
tiation conditions (data not shown). To verify if this
phenomenon depends on more restricted precursors
being present in neurosphere-derived populations, we
generated homogenous cultures of multipotent neural
stem cells (NS cells). These populations were generated
from murine embryonic stem cells. Also in NS cell cul-
tures, GFAP
+/bIII-tubulin
+ cells were induced even
though the part of NS cell-derived GFAP
+/bIII-tubulin
+
cells was smaller in comparison to neurosphere-derived
GFAP
+/bIII-tubulin
+ cells. This shows that IFNg can
generate this abnormal phenotype from immature
neural stem cells independently of the presence of neu-
ronal or glial precursors (Figure 4B). Thus, our experi-
ments suggest that IFNg can drive the differentiation of
NS cells or NSPC populations towards an immunocyto-
chemically abnormal marker profile, indicating a genetic
and/or functional dysregulation.
IFNg induces an abnormal down-stream signaling in
NSPCs
To study changes in IFNg receptor expression, we per-
formed quantitative real-time PCR after a 3-day IFNg
treatment of proliferative NSPCs. We detected increases
in the transcript numbers of IFNg-receptor1 and IFNg-
receptor2 (Figure 5A), as well as the IFNg-related down-
stream factor signal transducers and activators of tran-
scription 1 (Stat1). However, inducible nitric oxide
synthase (iNOS), a gene product, which is usually up-
regulated as a result of IFNg signaling, was down-regu-
lated, revealing another surprising effect of IFNg on
NSPCs (Figure 5A). We investigated IFNg-induced
changes of pro-neural basic helix-loop-helix (bHLH)
genes and the neurogenic transcription factor Pax6,
which are important for neuronal determination. Sup-
porting the notion that IFNg does not promote neuronal
determination, we found that Math1, Mash1, Neuro-
genin1 and Pax6 were down-regulated in NSPCs after
IFNg treatment (Figure 5B). Further, while IFNg
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Page 3 of 12Figure 2 IFNg reduces the population extent of NSPCs. In a: Optical densities [9] correlate to the extent of NSPC populations after a 48-hour
IFNg treatment with indicated concentrations. Values are means +/- standard error of mean (SEM). Experiments were performed in triplicate and
repeated independently at least three times. In b: Optical densities correlate to caspase 3/7 activity after a 48-hour IFNg treatment with indicated
concentrations. Values are means +/- standard error of mean (SEM). Experiments were performed in triplicate and repeated independently at
least three times. In c: Photomicrographs of caspase 3/7 immunocytochemistries are given for proliferating (NSPC-p) NSPCs with or without IFNg
treatment. Beta Actin labeling visualizes cytoplasmatic structures to better correlate the caspase 3/7 signal to single cells. In d: Photomicrographs
of BrdU labelings are given to visualize the amount of proliferating cells with or without IFNg treatment. Additionally, quantification of BrdU
+
cells is given. Values are means +/- standard error of mean (SEM). Experiments were performed in triplicate and repeated independently at least
three times. DAPI
+ nuclei are given in blue.
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Page 4 of 12Figure 3 Cell type-specific marker expression after IFNg treatment under proliferative conditions. In a: Results from real-time quantitative
PCRs expressed as ΔΔCT (IFNg- minus IFNg+) of PBS-treated control and IFNg-treated groups for the indicated markers of proliferating NSPCs.
Higher values indicate a higher gene expression. Values are means +/- standard error of mean (SEM). Experiments were performed in triplicate
and repeated independently at least three times. In b: Photomicrographs of proliferating NSPCs (NSPC-p) with indicated immunocytochemical
markers (GFAP, bIII-tubulin, Map2a-c). Yellow arrows mark GFAP
+/bIII-tubulin
+ cells, the red arrow marks a GFAP
-/bIII-tubulin
+ neuron and green
arrows mark GFAP
+/bIII-tubulin
- astrocytes. DAPI
+ nuclei are given in blue. Diagrams show the percentages of immuno-positive cells from all
DAPI
+-cells with (IFNg+) or without (IFNg-) IFNg treatment as indicated. Values are means +/- standard error of mean (SEM). Experiments were
performed in triplicate and repeated independently at least three times.
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Page 5 of 12Figure 4 Cell type-specific marker expression after IFNg treatment during differentiation. In a: Photomicrographs of NSPC populations
after a differentiation period of 7 days (NSPC-d) are given with indicated immunocytochemical markers and the corresponding quantification of
immuno-positive cells from all DAPI
+ cells with (IFNg+) or without (IFNg-) IFNg treatment as indicated. Values are means +/- SEM. Experiments
were performed in triplicate and repeated independently at least three times. In b: Photomicrographs of mouse embryonic stem cell-derived
neural stem cells (NS cells) differentiated for 7 days (NSC-d) with indicated immunocytochemical markers with (IFNg+) or without (IFNg-) IFNg
treatment are given. Yellow arrows mark GFAP
+/bIII-tubulin
+ cells. Red arrows mark GFAP
+/bIII-tubulin
- neurons and green arrows mark GFAP
-/
bIII-tubulin
+ astrocytes. Note the untypical morphology of GFAP
+/bIII-tubulin
+ cells under IFNg treatment in comparison to control. Values are
means +/- standard error of mean (SEM). Experiments were performed in triplicate and repeated independently at least three times.
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Gli1 was down-regulated, an effect that was unantici-
pated (Figure 5B).
GFAP
+/bIII-tubulin
+ cells exhibit non-neuronal and non-
astrocytic functional properties
To elucidate if the unusual effects of IFNg treatment on
the differentiation of NSPCs are accompanied by an atypi-
cal functional phenotype, we next analyzed basic electro-
physiological properties of GFAP
+/bIII-tubulin
+ cells. For
this purpose we combined whole-cell patch-clamp with
subsequent immunocytochemistry to unambiguously iden-
tify recorded cells. GFAP
+/bIII-tubulin
+ cells in IFNg-trea-
ted proliferative (n = 5) or differentiated (n = 9) cultures
almost exclusively exhibited an outward rectifying current-
voltage (IV) relationship (13/14 cells, Figure 6a-c). Small
inward currents were observed in 4/14 cells (Figure 6d).
When challenging GFAP
+/bIII-tubulin
+ cells within differ-
entiated cultures with current injections in current-clamp
mode, none of these cells exhibited action potentials when
depolarized to up to a membrane potential of approxi-
mately +30 mV (n = 7, Figure 6e, f). GFAP
+/bIII-tubulin
-
cells in differentiated cultures either exhibited an outward
rectifying IV relationship, similar to GFAP
+/bIII-tubulin
+
cells (3/6; Figure 6g, h, i), or a linear IV-relationship that
completely lacked voltage-dependent conductances (n =
3/6; Figure 6g, h, i). Such I/V relationships are typical for
mature classical astrocytes [14] and were never observed
in GFAP
+/bIII-tubulin
+ cells. Our electrophysiological
results, thus, demonstrate that GFAP
+/bIII-tubulin
+ cells
are functionally distinct from mature astrocytes as well as
neurons.
IFNg treatment impaired the formation of in vitro-
functional neural networks
To ultimately verify the effect of IFNg on NSPC popula-
tions, we performed experiments using the microelec-
trode array (MEA) technology, that is able to detect
functional neuronal network activity of entire neural
populations. Immature ES cell-derived nSFEB aggregates
consisting of a mixture of immature neural precursor
cells were exposed to IFNg during their initial 7-day pro-
liferation period under the influence of FGF-2. Hereafter,
IFNg was removed and differentiation was initiated by
FGF-2 withdrawal. By this paradigm, IFNg treatment
selectively hit developmental processes of ES cell-derived
NSPCs, while subsequent synapse formation and other
maturational processes were excluded from direct IFNg
influences. After the initial 7-day period, maturation of
cultures was observed for additional 44 days. Normally,
during the 3
rd and 4
th week, cultures start to develop
functional neuronal networks that show increasing burst
activity that finally ends in oscillating and synchronous
neuronal network activity (Figure 7, IFNg-). This syn-
chrony of action potential bursts in spatially distributed
neurons is expressed by the kappa value, with increasing
values showing higher network synchrony. By this experi-
ment we could show that a 7-day exposure to IFNg dur-
ing a developmentally sensitive period of immature
NSPCs under the influence of FGF-2 sustainably impairs
the subsequent generation of functional neuronal net-
works as burstrate and kappa levels were significantly
smaller in comparison to untreated populations (Figure
7). As neuronal network formation can also be impaired
by low cell densities, we verified this factor under IFNg-
treated conditions. However, even though IFNg led to a
reduced population extent, the 7-day proliferation period
was by far sufficient to allow for the growth of morpholo-
gically dense and confluent neural cell populations.
Discussion
Our results shed new light on the effects of IFNg
on NSPCs. Until now, IFNg-related up-regulation of
Figure 5 Down-stream signaling analysis after IFNg treatment
under proliferative conditions. In a and b: Results from real-time
quantitative PCRs expressed as ΔΔCT (IFNg- minus IFNg+) of PBS-
treated control and IFNg-treated groups for the indicated markers of
proliferative NSPCs. Higher values indicate a higher gene expression.
Values are means +/- standard error of mean (SEM). Experiments
were performed in triplicate and repeated independently at least
three times.
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of neurogenesis [7-9]. The present study disproves this
view and shows that IFNg instead promotes an abnormal
NSPC-derived cellular phenotype that does not relate to
classical neurons or astrocytes and that appears to be
dysregulated in terms of functional and molecular prop-
erties. IFNg treatment leads to the expression of both,
class III btubulin and GFAP in ~40% of NSPC which is
abnormal and, even after differentiation, not linked to
mature neuronal or astrocytic electrophysiological func-
tion. Class III btubulin isotype is usually considered
specific for post-mitotic neurons, and such aberrant
expression has so far only been noted in gliomas [15,16]
or dysregulated tumorigenic neural stem cells [17,18].
Walton and colleagues even report some unusual co-
expression of bIII-tubulin and GFAP in tumorigenic
neural stem cells, a phenomenon similar to that detected
here after IFNg treatment of regular NSPCs. The aspect
of IFNg-mediated NSPC dysregulation is further substan-
tiated in the present report by an up-regulation of SHH
which is paralleled by down-regulation of Gli1 which has
been reported to be consistently up-regulated in the
Figure 6 Patch-clamp results of IFNg treated NSPCs. In a: Voltage-step protocol used to probe cells for voltage-activated conductances (see
current traces in panels b-d, g, and h). In b, c: GFAP
+/bIII-tubulin
+ cells typically exhibited an outward rectifying current voltage (IV) relationship (13/
14 cells), IV-relationship was determined from non-leak-subtracted traces 10 ms after the voltage step (circle). In d: In 4/14 GFAP
+/bIII-tubulin
+ cells,
voltage-gated inward currents were observed in addition to outward currents. In e: Image of cell filled with Alexa Fluor350 and later identified as
GFAP
+/bIII-tubulin
+ (scale bar 30 μm, recordings illustrated in figure d) and f)). In f: None of the 14 GFAP
+/bIII-tubulin
+ cells exhibited action-
potential-like events, upon depolarization to at least -30 mV evoked by current injections (inset). In g, h: Membrane currents typically observed in
GFAP
+/bIII-tubulin
- cells (each recorded in 3/6 cells). In i: IV-relationships taken from non-leak-subtracted traces illustrated in g) (triangle) and h)
(square).
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Page 8 of 12course of SHH signaling [19]. As expression patterns of
neurogenic niche morphogenes like SHH or Gli1 are
generally tightly regulated during CNS development, its
disturbance points to misguided development or again
tumorigenesis [13,19]. Thus, for the first time, we directly
illustrated a possible link between IFNg,N S P C sa n dc e l -
lular abnormalities similar to that observed in tumor
cells strongly supporting the view that inflammation
m i g h tb ei n v o l v e di nt u m o rg e n e r a t i o nv i an e u r a ls t e m
cells. Additionally, the IFNg-related down-regulation of
iNOS in NSPC cultures is untypical as it is known that
IFNg normally induces iNOS [20]. Our electrophysiologi-
cal findings illustrate the importance of an additional
functional control of morphological/immunocytochem-
ical observations as the up-regulation of bIII-tubulin in
differentiated NSPC-derived cells, which was interpreted
as enhanced neurogenesis in different studies [7,9], was
not paralleled by neuronal electrophysiological behavior.
Further, the increase in GFAP
-/bIII-tubulin
+ neurons
after IFNg treatment of proliferating cultures was not sig-
nificant in the present study and after differentiation
under the impact of IFNg we even found significantly less
GFAP
-/bIII-tubulin
+ neurons. Interestingly, a similar
observation was described previously [21]. We found that
those bIII-tubulin expressing cells that significantly
increased in numbers after IFNg treatment of proliferat-
ing or differentiating cultures were also GFAP positive
and exhibited electrophysiological properties that were
neither typical for mature astrocytes nor for neurons. We
demonstrated this by careful correlating electrophysiolo-
gical data of patched cells with their immunocytochem-
ical phenotype. These molecular and functional IFNg
effects on NSPCs indicate a profoundly compromised
cell function or, alternatively, a new IFNg-induced
NSPC-derived neural cell of unknown function. Interest-
ingly, ectopic expression of IFNg during early stages of
CNS development induces medulloblastomas via SHH
overexpression [13] pointing towards a general dysregu-
lating effect of IFNg on NSPCs during development or
disease.
To investigate functional neural development under
controlled conditions, with and without IFNg-treatment,
we electrophysiologically measured the development of
functional neuronal networks starting from ES cell-
derived immature neural precursor cell cultures. Usually,
network activity progressively develops over time as a
result of a complex interaction of a multitude of factors
that converge to an integrated functional entity [22]. It
depends on efficient synapse formation and function of
an entire neuronal population. If using immature neural
precursor populations as developmental starting point,
basic aspects of functional neural development can be
measured. In contrast, mature ES cell-derived functional
neuronal networks can be used to detect acute func-
tional consequences due to changes in extracellular
composition. These investigations then affect already
active neuronal networks. For instance, they showed to
reversibly alter their network function under the influ-
ence of different cerebrospinal fluid specimens [23]. We
chose a paradigm in which the influence of IFNg selec-
tively affected the initial proliferation period of cultures
that were subsequently held under normal differentiat-
ing conditions. IFNg-treated cultures showed a signifi-
cantly impaired development of neuronal network
function, impressively pointing to an IFNg-related, pro-
foundly altered functional development of neural pre-
cursor populations.
Conclusion
Thus, we speculate that abnormally high IFNg produc-
tion during development and CNS diseases might impair
Figure 7 MEA-recordings of mouse ES cell-derived neural
populations. In a + b: Different electrophysiological parameters of
MEA-recordings with or without IFNg treatment in differentiated
mouse ES cell-derived neural precursor cells at indicated time points
are illustrated. In a: The synchrony of the neural network which is
expressed in kappa values. In b: Bursts per minute are given. In a,
the student´s t-test is applied. In b, linear regression is given with
p- and F-values and, additionally, the t-test is performed for the 51
days in vitro time point. Values are means +/- standard error of
mean (SEM). Experiments were performed in triplicate and repeated
independently at least three times.
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or adult regeneration and propose to inhibit IFNg effects
on NSPCs as a means to effectively support their devel-
opmental and regenerative potential.
Materials and methods
Neurosphere cultures
Neurospheres were generated from fourteen-day-old wild-
type C57BL/6J mouse embryos. Ganglionic eminences
were removed, mechanically dissociated and seeded in
DMEM/F12 culture medium (1:1; Invitrogen, Karlsruhe,
Germany) containing 0.6% Glucose (Sigma-Aldrich, Ham-
burg, Germany), glutamine (2 mM; Invitrogen), sodium
bicarbonate (3 mM; Invitrogen), Hepes buffer (5 mM;
Invitrogen) and B27 (20 μl per ml; Invitrogen). For genera-
tion and expansion of neurosphere cells, epidermal growth
factor (EGF) (Tebu-bio, Le Perray en Yvelines Cedex,
France) and basic fibroblast growth factor-2 (FGF-2)
(Tebu-bio) were added to a final concentration of 20 ng
per ml each.
Generation of embryonic stem cell-derived neural
stem cells
Undifferentiated ES cells (SV-129, ATCC, Millipore,
Billerica, USA) were grown under feeder-deprived con-
ditions in the presence of 1000 U/ml leukemia inhibi-
tory factor (LIF, Millipore) and 20% fetal bovine serum
(FBS, HyClone, Thermo Fisher Scientific, Schwerte,
Germany) in ES cell medium described elsewhere [24].
Neural differentiation of immature ES cells into neural
stem cell (NS cells) was performed according to modi-
fied protocols [22,25].
IFNg treatment and immunocytochemistry
For immunocytochemistry, neurosphere cells or ES cell-
derived NS cells were dissociated to a single cell suspen-
sion and plated on poly-L-ornithine (PLO; 0.001%;
Sigma-Aldrich) and fibronectin (5 μg/ml; Tebu-bio)
coated cover slips (VWR International, Darmstadt,
Germany) at a density of 50 × 10
3 cells per ml. After 3
days under the influence of EGF and FGF-2 (20 ng/ml
both Tebu-bio), cells were assigned to the different
experimental groups. To verify the marker expression of
undifferentiated (proliferating) neural populations under
control or IFNg treated conditions, cultures were kept
under the influence of EGF/FGF-2 without or with IFNg
(1000 U/ml; Millipore) until fixation after further 3 days
(NSPC-p -IFNg/+IFNg). To verify cell-type specific mar-
ker expression in differentiated cultures, growth factors
were withdrawn and then, cells were treated for 7 days
without or with IFNg until fixation (NSPC-d -IFNg/
+IFNg). For control experiments, only phosphate-buf-
fered saline solution (PBS; 1X; Invitrogen) was added to
the medium. Primary antibodies used at 4°C overnight
were monoclonal mouse antibodies to 5-bromo-2-deox-
yuridine (BrdU; 1:1000, Sigma-Aldrich), bIII-tubulin
(Tuj1; 1:500; R&D Systems, Minneapolis, USA or 1:800,
Abcam, Cambridge, UK), Map2a-c (1:2000; Sigma-
Aldrich), Sox2 (1:50; R&D Systems), IFNg-R1 (1:500;
Santa Cruz Biotechnology) and beta Actin (1:100; Milli-
pore) and polyclonal rabbit antibodies to glial fibrillaric
acid protein (GFAP) (1:500; Dako, Hamburg, Germany
or 1:1000; Abcam), caspase (1:100; Cell Signaling),
IFNg-R2 (1:500; Santa Cruz Biotechnology) and nestin
(1:200; Covance). BrdU labeling is described elsewhere
(Wellen et al., 2009). For detection of primary antibo-
dies, fluoresceine-isothiocyanate (FITC; 1:500; Millipore)
and indocarbocyanine (Cy3; 1:800; or Cy5; 1:200; Milli-
pore) coupled secondary antibodies were used. For nega-
tive controls, primary antibodies were omitted in each
experiment. To measure the total population of cells,
Dapi positive cell nuclei were counted. On every cover
slip, at least 100 cells were counted.
MTT-Assay
To analyze the population extent of NSPCs, the optical
density [9], indicative of conversion of 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT; Sigma-Aldrich) into formazan crystals which
takes place in live cells only, was determined after
IFNg treatment at decreasing concentrations as indi-
cated. An OD value of 0.5 represents approximately
50,000, and an OD value of 1.0 represents approxi-
mately 100,000 live NSPCs. The population extent
was measured after 48 hours of IFNg treatment as
indicated.
Caspase-activity Assay
For detection of caspase 3/7 activity after IFNg treat-
ment, we used the Caspase-Glo 3/7 assay (Promega,
Madison, USA). Proliferating cultures were treated with
decreasing concentrations of IFNg as indicated. Adding
the assay components to cultivated cells leads to cell
lysis and release of caspase 3/7. Caspase 3/7 is capable
of cleaving a tetrapeptide sequence substrate; this is dis-
mantled by luciferase which is a component of the
assay. The resulting light emission is then a measure of
caspase activity.
Quantitative real-time PCR
RNeasy Kit (Qiagen) was used for RNA isolation of cul-
tured NSPCs. Then a reverse transcription into cDNA
(ABI, Darmstadt, Germany) was performed. Quantitative
real-time PCR was carried out by the usage of the 7500
fast or 7500 quantitative real-time PCR cycler (ABI,
Darmstadt, Germany). Either SYBR green master mix
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(Quantace, London, UK) was used. The specific primer
for genes of interest or the housekeeping gene (glyceral-
dehyde-3-phosphate dehydrogenase, GAPDH) was either
purchased (QuantiTect primer assays, Qiagen) or self
designed (BioTEZ, Berlin, Germany). The genes of inter-
est (target gene) in IFNg-treated groups or control
groups (PBS-treated) were analyzed in at least 3 inde-
pendent cultures in triplicate each. Every experiment in
IFNg-treated or control (PBS-treated) groups provided
delta CT values (ΔCT: gene of interest minus house-
keeping gene). The presented graphs are ΔΔCT values:
ΔΔCT Ct  Ct
Ct
target gene housekeeping gene PBS-treated
ta
=
−
()
( r rget gene housekeeping gene IFN -treated  Ct − ) γ
Patch-clamp recordings
Somatic whole-cell patch-clamp recordings were carried
out using an Axopatch 200B amplifier (Molecular
Devices, Sunnyvale, CA, USA) coupled to a personal
computer via a digidata 1322A interface (Molecular
Devices). Data were acquired at 10 kHz using PClamp
8.2 software (Molecular Devices). Patch pipettes were
pulled from borosilicate glass (Hilgenberg, Waldkappel,
Germany) and had a resistance of 3-6 MΩ when filled
with intracellular solution containing (in mM): 120 K-
MeSO3, 32 KCl, 10 HEPES (N-(2-Hydroxyethyl)pipera-
zine-N’-(2-ethanesulfonic acid), 4 NaCl, 4 Mg-ATP and
0.4 Na-GTP, 1 Alexa Fluor 350 (Molecular Probes/Invi-
trogen), pH 7.30 (calculated liquid junction potential:
12.5 mV). Cells were held at membrane potentials of
-70 mV. To separate passive conductances from voltage-
gated currents, online leak subtraction (P/4) was per-
formed. Extracellular solution during patch-clamp
experiments contained in mM: 125 NaCl, 2.5 KCl, 2
CaCl2,1M g C l 2,1 . 2 5N a H 2PO4,2 6N a H C O 3,a n d2 0
glucose, bubbled with 95% O2 and 5% CO2 to result in
a pH of 7.4. Patch-clamp data were processed and ana-
lyzed using IGOR Pro-Software (WaveMetrics, Inc.,
Lake Oswego, OR). After the recordings, patch-pipettes
were carefully withdrawn and coverslips were trans-
ferred into 4% paraformaldehyde for 20 minutes at
room temperature. Thereafter coverslips were kept in
PBS (Invitrogen) at 4 °C until they were processed for
GFAP and btubulin immunocytochemistry. By means of
fluorescence at 350 nm electrophysiologically recorded
cells were identified and assigned either to GFAP
+/bIII-
tubulin
+ or GFAP
+/bIII-tubulin
- cells.
Microelectrode array recordings
For microelectrode array (MEA) recordings, 5 to 10
neural precursor cell-enriched, serum-free, floating
embryoid body-like aggregates (nSFEBs) [22] were
seeded on poly-D-lysine (PDL, 15 μg/ml, Sigma-Aldrich,
Germany) and laminin (15 μg/ml, Sigma-Aldrich, Ger-
many) coated MEAs with a square grid of 60 planar Ti/
TiN electrodes (30-μm diameter, 200-μm spacing) and
an input impedance of <50 kÙ according to the specifi-
cations of the manufacturer (Multi Channel Systems,
Reutlingen, Germany). Signals from all 60 electrodes
were simultaneously sampled at 25 kHz, visualized and
stored using the standard software MC Rack provided
by Multi Channel Systems. Spike and burst detection
was performed off-line by custom-built software (Result,
Düsseldorf, Germany). nSFEBs were kept for 7 days
after plating under the influence of FGF-2 (20 ng/ml,
PeproTech) only (IFN-g - group) or together with IFN-g
(1000 U/ml; IFN-g + group). After 7 days, FGF-2 and
IFN-g were removed from the medium to induce term-
inal differentiation. For long-term culture, ES cell-
derived neuronal networks were kept in DMEM/F12
(Gibco) supplemented with N2, B27 and Glutamax (all
Invitrogen). MEA recordings were performed at the
indicated time points.
Statistical analyses
Experiments were repeated with independent cultures at
least three times in triplicate each. The resulting data
sets were statistically analyzed und illustrated using the
GraphPad Prism 4 (GraphPad Software Inc., San Diego,
CA, USA, 2003) software. For approval of statistical sig-
nificance between groups a two-tailed t-test was per-
formed. P values < 0.05 were considered to indicate
significant differences. For comparison of functional
neuronal network development, slopes of linear regres-
sions were calculated with GraphPad Prism 4 and p-
and F-values were given.
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